Exousia Bio LMMY
OTC LMMY
$0.02 +0.00 (+26.67%)
At close: Sep 2, 2026 · 4:00 PM EDT

Exousia Bio (LMMY) Net Margin (2023 - 2024)

Exousia Bio (LMMY) posted Net Margin of 104.29% for Q3 2024, up 25.55% sequentially from 140.08% in Q2 2024.

Analysis

Exousia Bio (LMMY) Net Margin (2023 - 2024) Analysis & Trends

Exousia Bio (LMMY) has 2 years of Net Margin data on file, last reported at 104.29% in Q3 2024.

  • Quarterly Net Margin changed N/A year-over-year to 104.29% in Q3 2024, while the trailing twelve-month figure through May 2025 was 3388.88% (up 361329.0% YoY) and the FY2025 annual result came in at 1370.53%, up 159494.0% from the prior year.
  • Net Margin improved to 104.29% in Q3 2024 per LMMY's latest filing, from 140.08% in the prior quarter.
  • The five-year high for Net Margin was 92.21% in Q4 2023, with the low at 140.08% in Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 New Oriental Education & Technology 94.85 Bn 92.11 Bn 812.22 Mn 7.27%
2 Laureate Education 5.09 Bn 4.93 Bn 237.67 Mn 22.26%
3 Graham Holdings 4.81 Bn 3.57 Bn 777.03 Mn 21.68%
4 Covista 4.54 Bn 4.14 Bn 284.63 Mn 14.31%
5 Grand Canyon Education 4.00 Bn 3.72 Bn 204.08 Mn 17.37%
6 Stride 3.70 Bn 2.74 Bn 217.28 Mn 12.81%
7 McGraw Hill 2.54 Bn 2.35 Bn 439.20 Mn 10.52%
8 Perdoceo Education 2.10 Bn 792.68 Mn 162.46 Mn 22.48%
9 TAL Education 1.94 Bn -742.06 Mn 227.32 Mn 4.55%
10 Exousia Bio 368,824.87 368,824.87 -62,108.00 -
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2024 -104.29%
May 31, 2024 -140.08%
Feb 29, 2024 -124.39%
Nov 30, 2023 -92.21%